Co-Authors
This is a "connection" page, showing publications co-authored by Resham Bhattacharya and Shailendra Dwivedi.
Connection Strength
6.272
-
Small Non-Coding-RNA in Gynecological Malignancies. Cancers (Basel). 2021 Mar 03; 13(5).
Score: 0.724
-
Targeting the TGFß pathway in uterine carcinosarcoma. Cell Stress. 2020 Aug 25; 4(11):252-260.
Score: 0.698
-
KRCC1: A potential therapeutic target in ovarian cancer. FASEB J. 2020 02; 34(2):2287-2300.
Score: 0.666
-
Therapeutic evaluation of microRNA-15a and microRNA-16 in ovarian cancer. Oncotarget. 2016 Mar 22; 7(12):15093-104.
Score: 0.514
-
Corrigendum to 'Bmi-1: At the crossroads of physiological and pathological biology' [Genes & Diseases 2 (2015) 225-239]. Genes Dis. 2015 12; 2(4):353.
Score: 0.504
-
Role of TGF-ß signaling in uterine carcinosarcoma. Oncotarget. 2015 Jun 10; 6(16):14646-55.
Score: 0.487
-
Bmi-1: At the crossroads of physiological and pathological biology. Genes Dis. 2015 Sep; 2(3):225-239.
Score: 0.483
-
Secrets of DNA-PKcs beyond DNA repair. NPJ Precis Oncol. 2024 Jul 23; 8(1):154.
Score: 0.229
-
A role for the cystathionine-?-synthase /H2S axis in astrocyte dysfunction in the aging brain. Redox Biol. 2023 Dec; 68:102958.
Score: 0.218
-
The deubiquitinase USP10 protects pancreatic cancer cells from endoplasmic reticulum stress. NPJ Precis Oncol. 2022 Dec 21; 6(1):93.
Score: 0.205
-
KRCC1, a modulator of the DNA damage response. Nucleic Acids Res. 2022 10 28; 50(19):11028-11039.
Score: 0.203
-
Cystathione ß-synthase regulates HIF-1a stability through persulfidation of PHD2. Sci Adv. 2020 07; 6(27).
Score: 0.173
-
Inhibition of BMI1, a Therapeutic Approach in Endometrial Cancer. Mol Cancer Ther. 2018 10; 17(10):2136-2143.
Score: 0.151
-
Evaluating the Mechanism and Therapeutic Potential of PTC-028, a Novel Inhibitor of BMI-1 Function in Ovarian Cancer. Mol Cancer Ther. 2018 01; 17(1):39-49.
Score: 0.144
-
BMI1, a new target of CK2a. Mol Cancer. 2017 03 07; 16(1):56.
Score: 0.137
-
Mitochondrial BMI1 maintains bioenergetic homeostasis in cells. FASEB J. 2016 12; 30(12):4042-4055.
Score: 0.133
-
MDR1 mediated chemoresistance: BMI1 and TIP60 in action. Biochim Biophys Acta. 2016 08; 1859(8):983-93.
Score: 0.131
-
Cystathionine ß-synthase regulates endothelial function via protein S-sulfhydration. FASEB J. 2016 Jan; 30(1):441-56.
Score: 0.124
-
VEGF signaling: Role in angiogenesis and beyond. Biochim Biophys Acta Rev Cancer. 2024 Jan 26; 1879(2):189079.
Score: 0.055
-
Gold Nanoparticles Disrupt the IGFBP2/mTOR/PTEN Axis to Inhibit Ovarian Cancer Growth. Adv Sci (Weinh). 2022 11; 9(31):e2200491.
Score: 0.050
-
Disabling partners in crime: Gold nanoparticles disrupt multicellular communications within the tumor microenvironment to inhibit ovarian tumor aggressiveness. Mater Today (Kidlington). 2022 Jun; 56:79-95.
Score: 0.048
-
MicroRNA-195 controls MICU1 expression and tumor growth in ovarian cancer. EMBO Rep. 2020 10 05; 21(10):e48483.
Score: 0.044
-
Cystathionine beta synthase regulates mitochondrial dynamics and function in endothelial cells. FASEB J. 2020 07; 34(7):9372-9392.
Score: 0.043
-
Multifunctional APJ Pathway Promotes Ovarian Cancer Progression and Metastasis. Mol Cancer Res. 2019 06; 17(6):1378-1390.
Score: 0.039
-
MICU1 drives glycolysis and chemoresistance in ovarian cancer. Nat Commun. 2017 05 22; 8:14634.
Score: 0.035
-
Gold Nanoparticle Reprograms Pancreatic Tumor Microenvironment and Inhibits Tumor Growth. ACS Nano. 2016 12 27; 10(12):10636-10651.
Score: 0.033